These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23487226)

  • 21. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manic symptoms during a switch from risperidone to paliperidone: a case report.
    Yang FW; Liang CS
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E29. PubMed ID: 21948917
    [No Abstract]   [Full Text] [Related]  

  • 23. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia.
    Gilday E; Nasrallah HA
    Rev Recent Clin Trials; 2012 Feb; 7(1):2-9. PubMed ID: 22023179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paliperidone extended-release tablets: a new atypical antipsychotic.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 May; 45(5):15-8. PubMed ID: 17526326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with paliperidone extended-release tablets in a case of resistant undifferentiated schizophrenia: clinical improvement with 12 mg and evaluation through 3TRE scale].
    Rusconi AC; Carlone C; Muscillo M; Piccione M
    Riv Psichiatr; 2009; 44(4):267-72. PubMed ID: 20066799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paliperidone palmitate for schizophrenia.
    Nussbaum AM; Stroup TS
    Schizophr Bull; 2012 Nov; 38(6):1124-7. PubMed ID: 22966147
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction between paliperidone and carbamazepine.
    Yasui-Furukori N; Kubo K; Ishioka M; Tsuchimine S; Inoue Y
    Ther Drug Monit; 2013 Oct; 35(5):649-52. PubMed ID: 24052066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecule of the month. Paliperidone.
    Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961
    [No Abstract]   [Full Text] [Related]  

  • 30. Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report.
    Vázquez-Bourgon J; Rodríguez-Rodríguez P; Gómez-Ruíz E; Artal J; Crespo-Facorro B
    Ann Clin Psychiatry; 2014 Nov; 26(4):301-2. PubMed ID: 25401718
    [No Abstract]   [Full Text] [Related]  

  • 31. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kramer M; Simpson G; Maciulis V; Kushner S; Vijapurkar U; Lim P; Eerdekens M
    J Clin Psychopharmacol; 2007 Feb; 27(1):6-14. PubMed ID: 17224706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paliperidone use in the elderly.
    Madhusoodanan S; Zaveri D
    Curr Drug Saf; 2010 Apr; 5(2):149-52. PubMed ID: 20406162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social interaction and drug attitude effectiveness in patients with schizophrenia.
    Tsai JK; Lin WK; Lung FW
    Psychiatr Q; 2011 Dec; 82(4):343-51. PubMed ID: 21499787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paliperidone (Invega) for schizophrenia.
    Med Lett Drugs Ther; 2007 Mar; 49(1256):21-3. PubMed ID: 17351558
    [No Abstract]   [Full Text] [Related]  

  • 37. Paliperidone extended-release for the treatment of schizophrenia.
    Marino J; Caballero J
    Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for residual insomnia in schizophrenia.
    Baandrup L; Jennum P; Lublin H; Glenthoj B
    Acta Psychiatr Scand; 2013 Jan; 127(1):81-2. PubMed ID: 23106614
    [No Abstract]   [Full Text] [Related]  

  • 39. Paliperidone-related Pisa syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):129-31. PubMed ID: 23288235
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of acute schizophrenia with paliperidone ER: predictors for treatment response and benzodiazepine use.
    Heres S; Don L; Herceg M; Bidzan L; Blanc M; Siracusano A; Maciulis V; Lahaye M; Schreiner A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():207-12. PubMed ID: 24096139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.